Skip to main content
SpringerLink
Log in

Brain metastases

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Despite advances in the treatment of cancer, brain metastases appear to be increasing in frequency and are associated with a poor prognosis. Type of tumor, age, performance status, and extent of systemic disease are important prognostic factors that should be taken into consideration when making treatment decisions. Patients with a good performance status and controlled systemic disease may benefit from aggressive focal therapies (surgery or radiosurgery). Whole brain radiotherapy seems to increase local control but is associated with the risk of delayed cognitive deterioration in long-term survivors. In spite of this, whole brain radiotherapy remains the standard of care for those patients with poorer prognosis and for the treatment of recurrence after focal therapy. Chemotherapy has a limited role in the treatment of brain metastases but should be considered in selected patient populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 1978, 19:579–592.

    PubMed  CAS  Google Scholar 

  2. Schouten LJ, Rutten J, Huveneers HA, et al.: Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002, 94:2698–2705.

    Article  PubMed  Google Scholar 

  3. Cairns RA, Khokha R, Hill RP: Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr Mol Med 2003, 3:659–671. Review of multiple steps involved in the development of metastases.

    Article  PubMed  CAS  Google Scholar 

  4. Chang EL, Hassenbusch SJ 3rd, Shiu AS, et al.: The role of tumor size in the radiosurgical management of patients with ambiguous brain metastases. Neurosurgery 2003, 53:272–280; discussion 280–281.

    Article  PubMed  Google Scholar 

  5. Gaspar LE, Scott C, Murray K, et al.: Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 2000, 47:1001–1006. Recursive partitioning of a large database divided the patients into three categories according to prognostic factors (KPS, age, and systemic disease status).

    Article  PubMed  CAS  Google Scholar 

  6. DeAngelis LM, Delattre JY, Posner JB: Radiation-induced dementia in patients cured of brain metastases. Neurology 1989, 39:789–796.

    PubMed  CAS  Google Scholar 

  7. Patchell RA, Tibbs PA, Walsh JW, et al.: A randomized trial surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494–500.

    Article  PubMed  CAS  Google Scholar 

  8. Vecht CJ, Haaxma-Reiche H, Noordijk EM, et al.: Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 1993, 33:583–590.

    Article  PubMed  CAS  Google Scholar 

  9. Mintz AH, Kestle J, Rathbone MP, et al.: A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996, 78:1470–1476.

    Article  PubMed  CAS  Google Scholar 

  10. Patchell RA, Tibbs PA, Regine WF, et al.: Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485–1489.

    Article  PubMed  CAS  Google Scholar 

  11. Bindal RK, Sawaya R, Leavens ME, et al.: Surgical treatment of multiple brain metastases. J Neurosurg 1993, 79:210–216.

    Article  PubMed  CAS  Google Scholar 

  12. Sperduto P, Scott C: Stereotatic radiosurgery with whole brain radiation improves survival in patients with brain metastases: report of Radiation Therapy Oncology Group phase III study 95–08. Int J Radiat Oncol Biol Phys 2002, 54(suppl).

  13. Sneed PK, Suh JH, Goetsch SJ, et al.: A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. Int J Radiat Oncol Biol Phys 2002, 53:519–526. Omission of up-front WBRT does not seem to compromise length of survival in patients treated with radiosurgery.

    Article  PubMed  Google Scholar 

  14. Antonadou D, Paraskevaidis M, Sarris G, et al.: Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol 2002, 20:3644–3650.

    Article  PubMed  CAS  Google Scholar 

  15. Bafaloukos D, Gogas H, Georgoulias V, et al.: Temozolomide in combination with docetaxel in patients with advanced melanoma: a phase II study of the Hellenic Cooperative Oncology Group. J Clin Oncol 2002, 20:420–425.

    Article  PubMed  CAS  Google Scholar 

  16. Villa S, Verger E, Gil M, et al.: Concomitant and adjuvant temozolomide (TMZ) and whole brain irradiation (WBI) on patients affected with brain metastases (BM): a randomized multicentric phase II trial. Int J Radiat Oncol Biol Phys 2003, 57:S132.

    Google Scholar 

  17. Abrey LE, Olson JD, Raizer JJ, et al.: A phase II trial of temozolomide for patients with recurrent or progressive brain metastases. J Neuro-oncol 2001, 53:259–265.

    Article  CAS  Google Scholar 

  18. Christodoulou C, Bafaloukos D, Kosmidis P, et al.: Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases. Ann Oncol 2001, 12:249–254.

    Article  PubMed  CAS  Google Scholar 

  19. Sepkowitz KA, Brown AE, Telzak EE, et al.: Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 1992, 267:832–837.

    Article  PubMed  CAS  Google Scholar 

  20. Forsyth PA, Weaver S, Fulton D, et al.: Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 2003, 30:106–112.

    PubMed  Google Scholar 

  21. Schiff D, DeAngelis LM: Therapy of venous thromboembolism in patients with brain metastases. Cancer 1994, 73:493–498.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, 10021, New York, NY, USA

    Antonio Marcilio Padula Omuro MD & Lauren Eileen Abrey MD

Authors
  1. Antonio Marcilio Padula Omuro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lauren Eileen Abrey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Omuro, A.M.P., Abrey, L.E. Brain metastases. Curr Neurol Neurosci Rep 4, 205–210 (2004). https://doi.org/10.1007/s11910-004-0040-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-004-0040-6

Keywords

Search

Navigation